Nihon Kohden Reports Progress on Share Buyback Program

Nihon Kohden Corporation ( (JP:6849) ) just unveiled an update.

Nihon Kohden Corporation has reported progress on its ongoing share buyback program authorized by its board in December 2025 under Japan’s Companies Act. Between February 1 and February 28, 2026, the company repurchased 1,052,800 common shares on the Tokyo Stock Exchange for about 1.79 billion yen through market purchases based on a discretionary transaction agreement.

Under the broader resolution, Nihon Kohden is permitted to buy back up to 3.8 million shares, or 2.33% of its outstanding stock excluding treasury shares, for a maximum of 5 billion yen through March 31, 2026. As of February 28, the cumulative repurchases reached 1,771,000 shares totaling approximately 2.9 billion yen, signaling an active capital return policy that can support shareholder value and optimize the firm’s capital structure.

The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1769.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.

More about Nihon Kohden Corporation

Nihon Kohden Corporation is a Japan-based medical device manufacturer listed on the Prime Market of the Tokyo Stock Exchange. The company focuses on developing and supplying medical electronic equipment, such as patient monitors and diagnostic systems, serving hospitals and healthcare providers in Japan and global markets.

Average Trading Volume: 611,792

Technical Sentiment Signal: Buy

Current Market Cap: Yen290.5B

For an in-depth examination of 6849 stock, go to TipRanks’ Overview page.